UNLABELLED: Mouse models take advantage of genetic manipulations that can be achieved in this species. There are currently two accepted mouse models of subarachnoid hemorrhage (SAH) and cerebral vasospasm (CVs). Both are technically demanding and labor intensive. In this study, we report a reproducible and technically feasible method to induce SAH, and subsequently CVs, in mice. We tested this model in multiple strains of mice that are commonly used for genetic manipulation. METHODS: SAH was induced in C57BL/6NCr, FVB, 129S1, BalbC and SJL mice, weighing 28-32 g, by an intracisternal vessel transection technique. Animals were perfused with India ink at 24h postprocedure and vessel diameters were quantified. Brain slices were obtained for hematoxylin-eosin staining (H&E) to look for vascular changes consistent with CVs. RESULTS: There was no mortality during or after the procedure. Four of the five mouse strains showed significant CVs at 24 h postprocedure characterized by decreased vessel diameter of the middle cerebral artery close to the Circle of Willis. Histologically, the vessel wall displayed significant corrugation and thickening, consistent with CVs. CONCLUSION: A novel mouse model to induce SAH is described and tested in several mouse strains. Four of the five strains used in this study developed CVs after the induction of SAH. The procedure is brief, straightforward, reproducible with low mortality, and applicable to commonly used background strains for genetically engineered mice.
UNLABELLED: Mouse models take advantage of genetic manipulations that can be achieved in this species. There are currently two accepted mouse models of subarachnoid hemorrhage (SAH) and cerebral vasospasm (CVs). Both are technically demanding and labor intensive. In this study, we report a reproducible and technically feasible method to induce SAH, and subsequently CVs, in mice. We tested this model in multiple strains of mice that are commonly used for genetic manipulation. METHODS:SAH was induced in C57BL/6NCr, FVB, 129S1, BalbC and SJL mice, weighing 28-32 g, by an intracisternal vessel transection technique. Animals were perfused with India ink at 24h postprocedure and vessel diameters were quantified. Brain slices were obtained for hematoxylin-eosin staining (H&E) to look for vascular changes consistent with CVs. RESULTS: There was no mortality during or after the procedure. Four of the five mouse strains showed significant CVs at 24 h postprocedure characterized by decreased vessel diameter of the middle cerebral artery close to the Circle of Willis. Histologically, the vessel wall displayed significant corrugation and thickening, consistent with CVs. CONCLUSION: A novel mouse model to induce SAH is described and tested in several mouse strains. Four of the five strains used in this study developed CVs after the induction of SAH. The procedure is brief, straightforward, reproducible with low mortality, and applicable to commonly used background strains for genetically engineered mice.
Authors: E Vafiadaki; A Reis; S Keers; R Harrison; L V Anderson; T Raffelsberger; S Ivanova; H Hoger; R E Bittner; K Bushby; R Bashir Journal: Neuroreport Date: 2001-03-05 Impact factor: 1.837
Authors: Rachel G Mesis; Haichen Wang; Frederick W Lombard; Robert Yates; Michael P Vitek; Cecil O Borel; David S Warner; Daniel T Laskowitz Journal: Neurosurg Focus Date: 2006-09-15 Impact factor: 4.047
Authors: Chih-Lung Lin; Tarkan Calisaneller; Naoya Ukita; Aaron S Dumont; Neal F Kassell; Kevin S Lee Journal: J Neurosci Methods Date: 2003-02-15 Impact factor: 2.390
Authors: Augusto Parra; Matthew J McGirt; Huaxin Sheng; Daniel T Laskowitz; Robert D Pearlstein; David S Warner Journal: Neurol Res Date: 2002-07 Impact factor: 2.448
Authors: Jose Javier Provencio; Valerie Swank; Haiyan Lu; Sylvain Brunet; Selva Baltan; Rohini V Khapre; Himabindu Seerapu; Olga N Kokiko-Cochran; Bruce T Lamb; Richard M Ransohoff Journal: Brain Behav Immun Date: 2016-02-09 Impact factor: 7.217
Authors: A P Coulibaly; W T Gartman; V Swank; J A Gomes; L Ruozhuo; J DeBacker; J J Provencio Journal: Neurocrit Care Date: 2020-08 Impact factor: 3.210
Authors: Vanessa Weyer; Máté E Maros; Andrea Kronfeld; Stefanie Kirschner; Christoph Groden; Clemens Sommer; Yasemin Tanyildizi; Martin Kramer; Marc A Brockmann Journal: J Cereb Blood Flow Metab Date: 2019-11-21 Impact factor: 6.200
Authors: Marcel A Kamp; Jasper H van Lieshout; Maxine Dibué-Adjei; Jasmin K Weber; Toni Schneider; Tanja Restin; Igor Fischer; Hans-Jakob Steiger Journal: Transl Stroke Res Date: 2017-01-30 Impact factor: 6.829
Authors: Axel Neulen; Michael Kosterhon; Tobias Pantel; Stefanie Kirschner; Hermann Goetz; Marc A Brockmann; Sven R Kantelhardt; Serge C Thal Journal: J Vis Exp Date: 2018-07-28 Impact factor: 1.355